Ponatinib

Overview

Ponatinib is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM, respectively.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | Bcr-Abl

Product Information

• Catalog No.: B0084-272000
• CAS No.: 943319-70-8
• Molecular Formula: C29H27F3N6O
• Molecular Weight: 532.56
• Purity: >98%

Source

Original product source